Aelea Commodities Ltd Q1 FY27 Earnings Analysis
Published 31 May 2026 | Agricultural Food & other Products | Market Cap: ₹301 Cr
Price
₹161
Market Cap
₹301 Cr
P/E Ratio
49.4
Revenue Rank
Margin Rank
Earnings Summary
- FY26 capacity was fully utilized; FY27 expected to deliver good growth primarily via better quality RCN processing leading to improved kernel recovery rates and operational efficiency (Page 19). - The company aims to continue a similar growth trajectory in FY27 as seen in FY26, with significant increases in both top line and bottom line expected due to deeper integration into the value chain. - Management refrains from providing specific numeric guidance for FY27 and FY28 but indicates confidence in maintaining strong growth rates. - EBITDA margins are maintained around 10-11%, consistent with industry standards. - Investment in CNSL (Cashew Nut Shell Liquid) extraction facilities is expected to enhance bottom-line contribution, with up to 10% EBITDA margin on CNSL products. - B2C segment currently represents about 1% of sales, with plans to grow organically over the next 10 years, potentially contributing improved profitability (~13-15% EBITDA margin in B2C). - Earnings Per Share (EPS) for FY26 stood at around Rs.
📊 Revenue & Sales Performance
Rank 2- FY26 capacity was fully utilized; FY27 expected to deliver good growth primarily via better quality RCN processing leading to improved kernel recovery rates and operational efficiency (Page 19). - Top-line growth in FY27 expected to be at a similar trajectory as FY26, though no precise numbers provided due to regulatory constraints (Page 17). - Incremental growth will come from existing distributors, institutional clients, and deeper value chain integration (Pages 14, 16). - Direct procurement from Africa at sea-transit level targeted in FY27 to improve sourcing consistency (Page 19). - Expansion into B2C segment is in early stages, currently only 1% of sales, with plans for gradual organic and profitable growth over 10 years (Page 17). - Capacity enhancements with CNSL phase two underway and phase three planned, contributing more to bottom-line than top-line in the medium term (Pages 14, 12). - Finance costs expected to rise with deeper value chain penetration supporting growth (Page 9).
📈 Profitability & Margins
Rank 3- The company aims to continue a similar growth trajectory in FY27 as seen in FY26, with significant increases in both top line and bottom line expected due to deeper integration into the value chain. - Management refrains from providing specific numeric guidance for FY27 and FY28 but indicates confidence in maintaining strong growth rates. - EBITDA margins are maintained around 10-11%, consistent with industry standards. - Investment in CNSL (Cashew Nut Shell Liquid) extraction facilities is expected to enhance bottom-line contribution, with up to 10% EBITDA margin on CNSL products. - B2C segment currently represents about 1% of sales, with plans to grow organically over the next 10 years, potentially contributing improved profitability (~13-15% EBITDA margin in B2C). - Earnings Per Share (EPS) for FY26 stood at around Rs. 10.46, with expectations for continued improvement aligned with revenue and profit growth.
🏗️ Capital Expenditure Plans
Yes- Phase two CNSL (Cashew Nut Shell Liquid) extraction facility capex is already committed and underway with expected commissioning around H2 FY27. - Phase three capex for CNSL is planned for the later part of FY27 after stabilizing phase two operations. - Ground-mounted solar installation execution is pending due to government policy approvals, while rooftop solar is completed. - Future capex will focus on scaling operations, renewable energy integration, and expansion into value-added products like biochar, activated carbon, biofuels. - Strategic focus includes deepening value chain to improve margins and increase direct sourcing (~60-65% direct sourcing in FY27 expected). - Longer-term 10-year strategy involves growth in food, feed, fuel, and fertility segments with sustainability at the core. - Incremental capital investments will support capacity expansion from 40 to 140 metric tonnes per day.
💰 Fundraising & Capital Structure
No information- The company has not explicitly mentioned any immediate plans for new fundraising through debt or equity. - Finance costs have increased significantly due to deeper value chain involvement, leading to higher short-term borrowings. - Phase two Capex is underway and mostly committed, with a small amount pending. - Phase three Capex will happen after stabilization of phase two, planned for the later part of the year. - Going forward, finance costs may increase as the company deepens its value chain. - No clear mention of fresh equity fundraising; focus appears to be on operational growth and Capex via existing or planned funding. - Guidance for FY27 and FY28 indicates continued growth but no explicit fundraising plans disclosed.
📋 Order Book & Pipeline
No informationThe transcript does not explicitly mention current or expected order book or pending orders for Aelea Commodities Limited. However, relevant insights include: - Capacity utilization is high, around 94-95%, indicating strong ongoing demand. - The company is focusing on deepening its value chain and increasing volumes, especially in cashew processing. - Growth is expected to continue in FY27 at a similar trajectory to FY26. - Expansion projects like CNSL Phase 2 are underway, with Phase 3 planned after stabilization, supporting future volume increases. - The company emphasizes consistency in supply and is actively sourcing better quality raw materials, including direct sourcing from Africa. - Institutional client onboarding and distribution network expansion are part of growth strategies, implying a strong potential order pipeline. No direct figures for order backlog or pending orders are disclosed in the call transcript.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Aelea Commodities Ltd Q1 FY27 results?
- FY26 capacity was fully utilized; FY27 expected to deliver good growth primarily via better quality RCN processing leading to improved kernel recovery rates and operational efficiency (Page 19). - The company aims to continue a similar growth trajectory in FY27 as seen in FY26, with significant increases in both top line and bottom line expected due to deeper integration into the value chain. - Management refrains from providing specific numeric guidance for FY27 and FY28 but indicates confidence in maintaining strong growth rates. - EBITDA margins are maintained around 10-11%, consistent with industry standards. - Investment in CNSL (Cashew Nut Shell Liquid) extraction facilities is expected to enhance bottom-line contribution, with up to 10% EBITDA margin on CNSL products. - B2C segment currently represents about 1% of sales, with plans to grow organically over the next 10 years, potentially contributing improved profitability (~13-15% EBITDA margin in B2C). - Earnings Per Share (EPS) for FY26 stood at around Rs.
What is Aelea Commodities Ltd share price analysis?
Aelea Commodities Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 49.4 with a market cap of ₹301. Investors should review the full earnings analysis for detailed insights.
Is Aelea Commodities Ltd planning capital expenditure?
- Phase two CNSL (Cashew Nut Shell Liquid) extraction facility capex is already committed and underway with expected commissioning around H2 FY27.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
